chlorpropamide has been researched along with cyclin d1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukumoto, M; Kakuda, S; Kuwahara, Y; Ochiai, Y; Shimura, T; Takai, Y | 1 |
1 other study(ies) available for chlorpropamide and cyclin d1
Article | Year |
---|---|
Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
Topics: Animals; Apoptosis; Cell Proliferation; Cell Survival; Chlorpropamide; Cisplatin; Cyclin D1; Cyclin-Dependent Kinase 4; Dose Fractionation, Radiation; Down-Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HeLa Cells; Hep G2 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Proto-Oncogene Proteins c-akt; Radiation Tolerance; Radiation-Sensitizing Agents; Signal Transduction; Xenograft Model Antitumor Assays | 2011 |